Company intelligence / Profile preview

Encore Dermatology, Inc.

Malvern, PA, United Statesencoredermatology.com ↗

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

Encore Dermatology is a privately held specialty pharmaceutical company focused on dermatological prescription therapies and medical devices. The company commercializes several established topical products for conditions such as atopic dermatitis, acne, psoriasis, and other skin disorders. It has expanded through acquisitions and in-license deals since its founding in 2015. Its leadership team includes experienced executives from previous successful dermatology ventures.

Therapeutic areas: Dermatology
Modalities: Small molecules (topical steroids and antibiotics)Topical emollientsMedical devices
Industry: Biotech

Drug pipeline

1 asset

hylatopic plus

Unknown

Partnerships

Valeant Pharmaceuticals North America LLC (acquisition of product rights)

Beyond the preview

Go deeper on Encore Dermatology, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Encore Dermatology, Inc..

Explore the full profile